Posted by on October 13, 2021 9:02 pm
Categories: Breaking News Epoch Times News

FDA Says J&J Booster Could Bolster Protection, but Not Enough Time to Independently Analyze Data

U.S. drug regulators on Wednesday said a second shot of Johnson & Johnson’s COVID-19 vaccine could bolster people’s protection against the disease, but that they did not have enough time to independently analyze the data the company submitted. Both Johnson & Johnson and Moderna are asking regulators to allow boosters for their vaccines following the Food and Drug Administration’s (FDA) clearance of a Pfizer booster for tens of millions of Americans. The primary series for the Moderna and Pfizer jabs, which each utilize messenger RNA technology, are two shots each. Johnson & Johnson (J&J) was trumpeted early this year for being a single-shot vaccine, but scientists with the company say waning effectiveness against infections means a booster is now needed. In a phase 3 clinical trial conducted by J&J, the single-shot jab showed no waning protection against moderate to severe COVID-19 in the United States, but some waning protection was …

Originally appeared on The Epoch Times

Read More

Leave a Reply

Your email address will not be published.